학술논문
Efficacy, tolerability, patient usability, and satisfaction with a 2 mL pre-filled syringe containing secukinumab 300 mg in patients with moderate to severe plaque psoriasis: results from the phase 3 randomized, double-blind, placebo-controlled ALLURE study
Document Type
Article
Author
Source
In: Journal of Dermatological Treatment . (Journal of Dermatological Treatment, 2022, 33(3):1718-1726)
Subject
Language
English
ISSN
14711753
09546634
09546634